H2 FY26 revenue growth expected to be better than H1
Management expects second half to be stronger than first half, driven by textile recovery and oil & gas ramp-up.
Fineotex Chemical · forward-looking guidance across the available source record.
Guidance tracker
Management expects second half to be stronger than first half, driven by textile recovery and oil & gas ramp-up.
Management guided for a minimum 15% year-on-year growth rate going forward, assuming geopolitical conditions improve.
Management is confident of securing significant orders from Indian government for Aqua Strike in the second half of FY26.
Management indicated that historical EBITDA margins average 22-23%, and they expect to maintain similar levels.
Management revised the CCT revenue target from 2030 to FY28, with Q4 FY26 as the baseline run-rate of ~$90-100 million.
Management expects blended EBITDA margins to improve to 18-20% in the near term, possibly within FY27.
CCT's manufacturing capacity is being doubled with $7 million capex already deployed; new machines being installed.
Agreement to acquire an additional 25% stake from founders by January 2028, increasing ownership to ~79-80%.